Thiopurine
Showing 1 - 25 of 88
Solid Tumor, Adult, Metastatic Cancer Trial in Copenhagen (Atezolizumab, 6-mercaptopurine, 6-thioguanine)
Active, not recruiting
- Solid Tumor, Adult
- Metastatic Cancer
- Atezolizumab, 6-mercaptopurine, 6-thioguanine
-
Copenhagen, DenmarkUniversity Hospital of Copenhagen, Rigshospitalet
Apr 26, 2022
Pancreatitis, IBD Trial in Jerusalem (Azathioprine)
Withdrawn
- Pancreatitis
- Inflammatory Bowel Diseases
-
Jerusalem, IsraelShaare Zedek
Mar 17, 2021
Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)
Recruiting
- Inflammatory Disease
- +2 more
- Infliximab subcutaneous
- Immunosuppressive Agents
-
Amsterdam, North Holland, NetherlandsAmsterdam UMC AMC
Sep 27, 2023
B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin
Recruiting
- B Acute Lymphoblastic Leukemia
- Ph-Like Acute Lymphoblastic Leukemia
- Cyclophosphamide
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 26, 2022
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- T Acute Lymphoblastic Leukemia
- T Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Jan 11, 2023
Crohn Disease, IBD, Stricture; Bowel Trial in Melbourne (Adalimumab Injection, Thiopurine, Endoscopic balloon dilatation)
Active, not recruiting
- Crohn Disease
- +2 more
- Adalimumab Injection
- +2 more
-
Melbourne, Victoria, AustraliaSt. Vincent's Hospital Melbourne
Oct 22, 2020
Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in
Terminated
- Philadelphia Chromosome Negative
- +2 more
- Blinatumomab
- +11 more
-
Houston, TexasM D Anderson Cancer Center
Nov 3, 2022
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic
Terminated
- Recurrent B Acute Lymphoblastic Leukemia
- +3 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Apr 28, 2022
Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- Cyclophosphamide
- +11 more
-
Houston, TexasM D Anderson Cancer Center
Nov 30, 2021
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Skejby, Odense, Copenhagen (Thioguanine (oral))
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Thioguanine (oral)
-
Skejby, Aarhus, Denmark
- +3 more
Apr 14, 2020
Acute Lymphoblastic Leukemia in Remission, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia
Terminated
- Acute Lymphoblastic Leukemia in Remission
- +2 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Mar 18, 2021
Drug Induced Neuropathy in Children With ALL
Recruiting
- Acute Lymphocytic Leukemia
-
Trieste, Friuli Venezia Giulia, ItalyIRCCS materno infantile Burlo Garofolo
Mar 31, 2023
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)
Recruiting
- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Blinatumomab
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Feb 21, 2021
Colitis, Ulcerative Trial in Netherlands (Mercaptopurine (Purinethol), Placebo, Mesalamine)
Unknown status
- Colitis, Ulcerative
- Mercaptopurine (Purinethol)
- +3 more
-
Alkmaar, Netherlands
- +11 more
Jan 6, 2020
Ulcerative Colitis Trial (MitoQ, Placebo)
Not yet recruiting
- Ulcerative Colitis
- MitoQ
- Placebo
- (no location specified)
Sep 13, 2022
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in United States
Completed
- Acute Lymphoblastic Leukemia
- Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
- Alemtuzumab
- +20 more
-
Palo Alto, California
- +100 more
Aug 3, 2022
Pediatric Acute Lymphoblastic Leukemia
Enrolling by invitation
- Acute Lymphoblastic Leukemia, Pediatric
- Adverse Drug Event
-
Stanford, CaliforniaStanford University
Mar 7, 2022
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Australia,
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Cyclophosphamide
- +12 more
-
Phoenix, Arizona
- +27 more
Apr 2, 2021
Local and Systemic Immunoprofiling of Patients Diagnosed With
Recruiting
- Ulcerative Colitis Flare
-
Nijmegen, Gelderland, NetherlandsRadboudUMC
Jan 10, 2023
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in United
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Calaspargase Pegol-mknl
- +14 more
-
Birmingham, Alabama
- +26 more
Apr 2, 2021
Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)
Not yet recruiting
- Atopic Dermatitis
- Baricitinib 4 MG
- Azathioprine 1.5-2.5 mg/kg
-
Sari, Mazandaran, Iran, Islamic Republic ofIran
Aug 1, 2023
Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Childhood T Acute Lymphoblastic Leukemia Trial in Worldwide
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Asparaginase
- +17 more
-
Birmingham, Alabama
- +169 more
Aug 17, 2022